acceler growth margin
increas forecast ebitda increas target price
mark market multipl maintain outperform rate
estim symris sustain ebitda margin mid-high singl
digit organ growth upsid margins/growth rate
support backward integr raw materi ramp-up signific
new capac believ market overli concern
temporari raw materi inflat creat attract buy
sustain margin ebitda margin
yoy demonstr resili busi face
rise raw materi price fx headwind forecast
price recoveri support fy margin flat
level symris well posit mitig impact
rise cost back integr raw materi place
compani favour negoti posit custom vs
invest set acceler growth symris
brought forward ramp diana food usa plant
jan given current capac constraint custom demand level
group forecast volum growth acceler
led ramp major invest project cosmet food
menthol estim cumul growth contribut six signific
growth project invest ramp
support mid-high singl digit organ growth mid-term peer
wider chemic sector
valuat target price averag peer multipl
dcf key risk outperform rate cost
inflat beyond expect
valuat metric
price month
price rel chart measur perform
deutsch bors dax close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
symris global provid fragranc flavor activ
ingredi aroma chemic well sensori nutrit
solut perfum cosmet pharmaceut food beverag
pet food babi food industri
price may rate outperform target price analyst mathew hampshire-waugh
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
digit growth ebitda multipl compar base
case scenario mid-high singl digit organ growth
ebitda margin ebitda multipl
digit growth ebitda multipl compar base
case scenario mid-high singl digit organ growth
ebitda margin ebitda multipl
price rel chart measur perform deutsch
bors dax close
spot exchang rate
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
increas forecast ebitda driven support margin scent
scent increas margin follow result
margin in-line expect exclud benefit price increas
manag guid price increas compens higher raw
materi cost assum divis recoup lost margin higher raw
materi cost move year
flavour nutrit increas top-line driven faster ramp
diana facil us reduc margin due weaker earn
probi
forecast organ ebitda growth driven organ revenu
growth non-organ item follow
cobel acquisit assum addit month cobel
improv margin
fx headwind weaker usd
new invest includ contribut pet food franc flavour
usa cosmet usa includ earli ramp diana food usa
equat ebitda contribut
renessenz/pinova synergi synergi
basf citral impact assum adjust margin due
raw materi price increas link basf citral outag equat
sale pinova industri
nutraceutix probi acquisit
new invest
basf citral impact
symris trade premium peer consensu month forward ev/ebitda
premium year averag trade line
month forward price-to-earnings basi symris current trade premium peer
premium year histor averag
peer averag euro stoxx rel
figur symris pe rel peer
figur symris ev/ebitda rel peer
compani mention price
